“JADE” plans to standardize sugar control and explore interactive management of chronic disease management with a sugar control rate of 95%.

The long course of disease, poor patient compliance, uneven management levels, and the traditional management mode of doctors' diagnosis and treatment have always been the "disease" of diabetes management.

After the “Hundred Sugar Battle” appeared in the mobile medical market in 2015, the diabetes app applied to patients' self-management experienced a round of shuffling before the market suddenly realized. For diabetes that requires continuous monitoring and control, there is almost no one. A product that can address self-management compliance.

Different from the path of the diabetes app from online to the offline expansion, before the founding of 7+1, founder Xu Jianqun went to the core first- and second-tier cities for market research, to understand the market demand, and to see the advantages and disadvantages of sugar-control APP. As well as the current medical system, analyze the behavior and psychology of patient control, and established the 7+1 Medical Center in 2016, and chose the “trust” model of the diabetes medical center from the offline.

7+1Medical Center real scene, respondents for the picture

Long-term diabetes has a great chance of causing complications, and more than half of the complications are due to cardiovascular disease, 10% are kidney disease, and patients with diabetes amputation are 10-20 times more likely to be non-diabetic. According to the World Health Organization, there are more than 100 complications of diabetes, which is the most common complication known. Therefore, blood glucose control is the foundation and core of diabetes management.

The difficulty of blood glucose control that plagues China's 114 million people with diabetes is twofold: there is no systematic control plan and lack of patient control awareness.

In the market, patients seeking blood glucose control are generally carried by two types of institutions/enterprises, one is services, such as hospitals and community health service centers, and the other is self-managed product categories, such as intelligent hardware/APP for diabetes management.

Hospitals are more often diagnosed and treated. Chronic diseases usually require long-term continuous blood glucose monitoring, personalized control, rather than uniform treatment. The hospital has authority and professionalism, but has no energy to do fine control, so it is difficult to control blood sugar. effect.

Xu Jianqun, founder and CEO of 7+1 Medical Center, believes that “whether it is a hospital, a social hospital, a pharmacy, or a smart hardware company, it is a single-point service, lacking systemicity and comprehensiveness.”

Xu Jianqun, founder and CEO of 7+1 Medical Center

The self-administered APP products of diabetes are usually a light consultation mode. It is difficult to ensure patient compliance and continuity of treatment. The profitability depends on the e-commerce embedded in the APP and is out of the medical track.

For diabetic patients, payment is a difficult problem, but it is not the biggest problem. Although the long-term investment in drugs and services makes the cost of chronic disease management higher, the root cause lies in the awareness of the disease and the urgency of management and control. This plays an important role.

"Most patients will have a chance to survive, and feel that there are no complications. It is actually poor cognitive ability and urgency. Therefore, it has become more difficult to operate the market for diabetes services."

Xu Jianqun is a management graduate with more than 12 years of experience in IPO and management consulting. He also served as CFO of listed companies.

In his team, there is also a heavyweight partner. Yan Pingyi, co-founder and consultant, was a founder of three medical companies - Mindray Bio, Redu Life Sciences and Micro-Biology, with more than 20 years of experience in medical and diagnostic equipment;

After observing the pain points and gaps in the diabetes market, Xu Jianqun conducted an eight-month market research on the diabetes market to explore the authenticity of the demand in the diabetes market. “We started thinking at the end of 14th, and then I combined some of the market conditions at the time of micro-point biology, communicated with many people with diabetes, and then slowly accumulated the 7+1 model.”

7+1Medical Center real scene, respondents for the picture

In view of the pain point of no systematic management and control program for diabetes management, Xu Jianqun found that in the Asian region, the Chinese University of Hong Kong's more than 30 years of research results JADE (Asia Diabetes Evaluation Program) has successfully succeeded more than 150,000 diabetics in Asia. For verification, there is currently no complete diabetes control system in China.

Based on this, 7+1 localized the “JADE” and established a standardized evaluation system based on JADE, which was applied to the 7+1 Medical Center to help more diabetic patients.

This standardized evaluation process, 7+1 is the only authorized organization in the Mainland. With the support of ADF, 7+1 brings a series of proven and effective diabetes risk control models to ADF and high-risk groups. Compared with the simple monitoring + intervention method of sugar control, JADE's model pays more attention to the comprehensive management of diabetes, providing patients with personalized risk assessment; nursing programs and treatment recommendations; practical advice to encourage self-management and coordination of diabetes patients and Joint decision-making between health care workers.

Asian Diabetes Assessment System (JADE) report template, for respondents

Compared with the traditional services of traditional medical institutions, that is, seeing and prescribing drugs, 7+1 Medical Center adds modules such as nutrition therapy and psychological care to form a differentiated service with traditional medical institutions. The offline entities mainly carry low-frequency nutrition therapy, psychological care and other membership services, while the high-frequency daily indicator monitoring and medication monitoring are remotely monitored by the 7+1 diabetes management platform to form a “physical low frequency” + “online high frequency” service. combination.

Different from other disciplines, there is no deep-rooted concept of “prestigious doctor” and “big expert” for diabetes. The doctor's IP is relatively vague. At 7+1Medical Center, medical staff need to participate in the ADF (Asia Diabetes Foundation) training and pass the examination. .

At present, in the flagship store opened in Changsha, there are 2 two associate professor doctors, 2 attending doctors, 4 dieticians and 4 nurses and 2 sports coaches, which constitute a medical treatment from sugar treatment to sugar control. The team provides exclusive multi-to-one services for shoppers.

Facing the patient's precise treatment with the whole person's diagnosis and treatment, the whole case planning, and the whole process management, the team of doctors, nurses, health managers and nutritionists cooperates. This is the 7+1 "sugar control secret recipe". Seven days a week, one heart and one mind is this. 7+1 "Gly sugar control concept".

In diabetes management, patient drainage and payment are the core challenges. At the beginning of its establishment, 7+1 Medical Center borrowed the media of local credibility, conveyed the brand and service concept, deeply in contact with patients in the way of inviting patients to enter the store experience, and then formed a systematic understanding of sugar management in the process of experience, and completed the payment. .

Chronic diseases are characterized by long course of disease and long management period. Receiving services in high-end medical institutions often means higher consumption, while chronic disease control is popularized medical treatment, and high-end medical care will reduce the frequency of services accordingly, so 7+1Medical Center is preferred. The city is a second-tier city like Changsha, which has both endorsement and drainage of Xiangya Hospital, as well as mature customers.

With high-quality professional services and sugar control effects, 7+1 continues to accumulate numbers and return visits. So far, 7+1 paid members have a repurchase rate/shop rate of over 90%. At present, during the one-year operation of the 7+1 Diabetes Medical Center, more than 2,400 diabetic patients have been served, including more than 300 annual fee members, and the effectiveness of control is 95%.

Holding the data on the effectiveness of sugar control at hand, after a year of product polishing, and analysis of the market and target population portraits, United Ping An Insurance Company launched the market's first effective sugar-reducing insurance plan for diabetes, 7+1Medical Center and Ping An Insurance jointly developed diabetes insurance, which enabled the 7+1 Medical Center service to solve the patient's payment barriers while expanding the access to insurance sales channels.

Founder Xu Jianqun introduced "the customer resources that insurance sales personnel have, it is the purchaser of the product, young, discerning ability, fast payment decision, can be purchased for the family." Introducing commercial insurance into the field of chronic disease control, 7+1 is responsible for controlling the risk to achieve risk control. On the other hand, insurance sales ability and customer resources can make up for the early drainage and payment problems of chronic disease mode.

Patients can enjoy 7+1 diabetes control service by purchasing insurance packages. The online service entrance is mainly output by Ping An Doctor. In cities without 7+1 stores, the offline service will be undertaken by Wanjia clinic, and the patient data will be handed over to 7+1. Diabetes management platform for remote monitoring and management.

At the same time, the policy adopts the latest interactive policy form, and sets the sugar control reward mechanism. Within one year of sugar control, the key indicators can reach the effective control scope, and the next year's premium can be reduced, and patients with excellent sugar control performance can be selected. Give certain rewards to improve compliance with control.

7+1 Medical Center's operational process, provided by respondents

Relative to the chronic disease management of the Internet, the 7+1 slave mode makes full use of the convenience of the Internet, solves the daily control problems of patients and monitors the whole process, and continues the remote follow-up by the team. At the same time, the entity control center that establishes the medical differentiated service is Low frequency and high frequency control behavior during treatment and management. In the overall treatment and management process, On-Line and Off-Line control ratios form a rationalized closed loop.

In terms of product form, 7+1 used the Asian Diabetes Foundation (ADF) 10-year research technology JADE to establish a core standard control program for chronic disease management, and combined with commercial insurance to create the market's first effective diabetes hypoglycemic insurance program, which was sold throughout the network.

As a new star in the field of diabetes, according to Xu Jianqun, the next step of the 7+1 Medical Center will continue to expand the market in Changsha, Guangzhou, Shenzhen and Zhejiang. The three-year plan is to land 10 stores. Previously, the 7+1 Medical Center completed the angel round of financing. After the first store's business model was verified, the 7+1 in the copying stage was actively engaging with capital.

“Severe disease management is a social problem. How to establish systematic and effective control? How to establish a correct understanding of diabetes? Relevant institutions in the health industry need to participate together to manage this huge slow patient population in the Chinese population. "Xu Jianqun said.

Oxygen Therapy

Oxygen Mask,venturi mask,tracheostomy mask,nasal cannula

2 MEDS TECHONOLOGY CO.,LTD , https://www.2-meds.com